Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates
📄 Original study ↗Plain English Summary
This review digs into what happens in the brain when psilocybin (the active ingredient in magic mushrooms) triggers full-blown mystical experiences — and the numbers are striking. Under carefully controlled lab conditions, a single dose produced complete mystical experiences in roughly 60% of volunteers, with effects still felt over a year later. Researchers developed a validated questionnaire capturing four dimensions: mystical unity, positive mood, time and space dissolving, and the feeling that words just can't capture what happened. Here's where it gets really compelling: the strength of the mystical experience actually predicted how well psilocybin worked as therapy for addiction and cancer-related distress. The brain mechanism? The default mode network — a set of brain regions active during self-referential thinking — gets disrupted, much like what happens during deep meditation. This links psychedelic science to broader consciousness research, including phenomena like near-death experiences.
Actual Paper Abstract
This chapter begins with a brief review of descriptions and definitions of mystical-type experiences and the historical connection between classic hallucinogens and mystical experiences. The chapter then explores the empirical literature on experiences with classic hallucinogens in which claims about mystical or religious experiences have been made. A psychometrically validated questionnaire is described for the reliable measurement of mystical-type experiences occasioned by classic hallucinogens. Controlled laboratory studies show that under double-blind conditions that provide significant controls for expectancy bias, psilocybin can occasion complete mystical experiences in the majority of people studied. These effects are dose-dependent, specific to psilocybin compared to placebo or a psychoactive control substance, and have enduring impact on the moods, attitudes, and behaviors of participants as assessed by self-report of participants and ratings by community observers. Other studies suggest that enduring personal meaning in healthy volunteers and therapeutic outcomes in patients, including reduction and cessation of substance abuse behaviors and reduction of anxiety and depression in patients with a life-threatening cancer diagnosis, are related to the occurrence of mystical experiences during drug sessions. The final sections of the chapter draw parallels in human neuroscience research between the neural bases of experiences with classic hallucinogens and the neural bases of meditative practices for which claims of mystical-type experience are sometimes made. From these parallels, a functional neural model of mystical experience is proposed, based on changes in the default mode network of the brain that have been observed after the administration of classic hallucinogens and during meditation practices for which mystical-type claims have been made.
Research Notes
Key synthesis paper linking psychedelic neuroscience to consciousness studies. Directly extends Carhart-Harris et al. (2012) and Brewer et al. (2011) DMN findings. Relevant to the library as background on altered states of consciousness that overlap phenomenologically with reported psi experiences and NDEs.
Reviews the phenomenology, measurement, and neural correlates of mystical experiences occasioned by classic hallucinogens. Under double-blind conditions, psilocybin (30 mg/70 kg) produced complete mystical experiences in 57-67% of participants, with effects persisting at 14-month follow-up. The psychometrically validated 30-item Mystical Experience Questionnaire (MEQ30) captures four factors: Mystical, Positive Mood, Transcendence of Time and Space, and Ineffability. Mystical experience scores mediated therapeutic outcomes in addiction and cancer-related distress. Proposes a functional neural model in which disruption of the default mode network — particularly decreased activity in the medial prefrontal cortex, posterior cingulate cortex, and angular gyrus — underlies the unity and timelessness central to mystical experience, drawing parallels with meditation neuroimaging.
Links
Related Papers
Extends
Companion
More in Methodology
Paranormal belief, conspiracy endorsement, and positive wellbeing: a network analysis
Planning Falsifiable Confirmatory Research
Addressing Researcher Fraud: Retrospective, Real-Time, and Preventive Strategies — Including Legal Points and Data Management That Prevents Fraud
Quantum Aspects of the Brain-Mind Relationship: A Hypothesis with Supporting Evidence
Paranormal beliefs and cognitive function: A systematic review and assessment of study quality across four decades of research
📋 Cite this paper
Barrett, Frederick S, Griffiths, Roland R (2018). Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates. Current Topics in Behavioral Neurosciences. https://doi.org/10.1007/7854_2017_474
@article{barrett_griffiths_2018_hallucinogens_mystical,
title = {Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates},
author = {Barrett, Frederick S and Griffiths, Roland R},
year = {2018},
journal = {Current Topics in Behavioral Neurosciences},
doi = {10.1007/7854_2017_474},
}